Note: Ingredients listed on restricted chemical lists
EC/CAS
123-86-4
Name of the chemical
acetic acid, butyl ester
Concentration
≥10-≤30
EC/CAS
64742-95-6
Name of the chemical
Solvent naphtha (petroleum), light arom
Concentration
≥3-≤7
EC/CAS
1333-86-4
Name of the chemical
carbon black
Concentration
≥1-≤5
EC/CAS
61789-86-4
Name of the chemical
Sulfonic acids, petroleum, calcium salts
Concentration
≥1-≤5
EC/CAS
91-20-3
Name of the chemical
Naphthalene,3
Concentration
≥0.1-≤1
EC/CAS
868-77-9
Name of the chemical
2-hydroxyethyl methacrylate
Concentration
≥0.1-≤1
EC/CAS
98-82-8
Name of the chemical
Cumol (2022/692)
Concentration
≥0.1-≤1
General Information
Version
26
Revision date
2026-08-21
Product name
R-CURE 800 1E1952H FD MEDIUM GLOSS BLACK URETHANE
supplier name
Compania Sherwin-Williams S.A. de C.V
Emergency telephone
(800) 424-9300
Icons in SDS
Company Information
company name
Compania Sherwin-Williams S.A. de C.V
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H226, H304, H317, H336, H351
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture FLAMMABLE LIQUIDS - Category 3 SKIN SENSITIZATION - Category 1 CARCINOGENICITY - Category 2 SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Narcotic effects) - Category 3 ASPIRATION HAZARD - Category 1
Ingredient(s) with unknown acute toxicity
15.2% (oral), 19.4% (dermal), 21% (inhalation)
Signal word
Danger
Hazard statements
H226 - Flammable liquid and vapor. H304 - May be fatal if swallowed and enters airways. H317 - May cause an allergic skin reaction. H336 - May cause drowsiness or dizziness. H351 - Suspected of causing cancer.
Prevention
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves, protective clothing and eye or face protection. P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P271 - Use only outdoors or in a well-ventilated area. P261 - Avoid breathing vapor. P272 - Contaminated work clothing must not be allowed out of the workplace.
Response
P308 + P313 - IF exposed or concerned: Get medical advice or attention. P304 + P340, P312 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or doctor if you feel unwell. P301 + P310, P331 - IF SWALLOWED: Immediately call a POISON CENTER or doctor. Do NOT induce vomiting. P303 + P361 + P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P333 + P313 - If skin irritation or rash occurs: Get medical advice or attention.
Storage
P405 - Store locked up. P403 + P233 - Store in a well-ventilated place. Keep container tightly closed.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
DELAYED EFFECTS FROM LONG TERM OVEREXPOSURE. Contains solvents which can cause permanent brain and nervous system damage. Intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal. WARNING: This product contains chemicals known to the State of California to cause cancer and birth defects or other reproductive harm. FOR INDUSTRIAL USE ONLY. This product must be mixed with other components before use. Before opening the packages, READ AND FOLLOW WARNING LABELS ON ALL COMPONENTS. Please refer to the SDS for additional information. Keep out of reach of children. Do not transfer contents to other containers for storage.
2.3 Other hazards
None known. Hazards identified when used : No known significant effects or critical hazards.
2.1 Classification of the substance or mixture
FLAMMABLE LIQUIDS - Category 3 substance or mixture SKIN SENSITIZATION - Category 1 CARCINOGENICITY - Category 2 SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Narcotic effects) - Category 3 ASPIRATION HAZARD - Category 1 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 15.2% (oral), 19.4% (dermal), 21% (inhalation)